A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy.
Ross BD, Jang Y, Welton A, Bonham CA, Palagama DSW, Heist K, Boppisetti J, Imaduwage KP, Robison T, King LR, Zhang EZ, Amirfazli C, Luker KE, Lee WY, Luker GD, Chenevert TL, Van Dort ME.
Ross BD, et al. Among authors: lee wy.
Nat Commun. 2022 Aug 17;13(1):4730. doi: 10.1038/s41467-022-32486-8.
Nat Commun. 2022.
PMID: 35977945
Free PMC article.